European Haemophilia Consortium: Day 1 At EHC Conference 2025 In Vienna – What A Start
European Haemophilia Consortium (EHC) posted on LinkedIn:
”Day 1 at EHC Conference 2025 in Vienna – What a Start
We kicked off with insights into haemophilia care in Austria, celebrating six decades of advocacy from Österreichische Hämophilie Gesellschaft (ÖHG), the Austrian Haemophilia Society, and learning from their national registry and treatment guidelines.
A powerful session on women’s health and bleeding disorders broke down barriers with discussions on diagnosis, menopausal management, and inspiring patient perspectives from symptomatic carriers.
The afternoon dove deep into von Willebrand Disease, exploring family mental health, the latest in genetics and screening, and a sneak peek at future treatments.
The day wrapped up with our General Assembly, where EHC National Member Organisation representatives came together for important discussions and decisions about our community’s future.
Thank you to our brilliant chairs, speakers, and all attendees. Looking forward to tomorrow’s sessions.”

Keep up with Hemostasis Today.
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026